Poupak Fallahi相关文献与解析，生知库 | 链接生命科学的每一步

Enke Baldini, Silvia Cardarelli, Antonio Francesco Campese, Eleonora Lori, Poupak Fallahi, Camilla Virili, Flavio Forte, Daniele Pironi, Filippo Maria Di Matteo, Piergaspare Palumbo, Maria Ludovica Costanzo, Vito D'Andrea, Marco Centanni, Salvatore Sorrenti, Alessandro Antonelli, Salvatore Ulisse

肿瘤

甲状腺癌

肿瘤细胞

发表日期：2024

文献求助收藏

Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer

人类甲状腺癌中的中性粒细胞胞外陷阱和中性粒细胞相关介质

期刊:Frontiers in Immunology

影响因子:5.7

doi:10.3389/fimmu.2023.1167404

Luca Modestino, Leonardo Cristinziano, Remo Poto, Annagioia Ventrici, Marialuisa Trocchia, Silvia Martina Ferrari, Poupak Fallahi, Sabrina Rosaria Paparo, Gianni Marone, Alessandro Antonelli, Gilda Varricchi, Maria Rosaria Galdiero

Increased neutrophil derived chemokines (CXCL10 and CCL2) in human trichinellosis as possible serological markers of the polarization of the immune response against the parasite

人类旋毛虫病中中性粒细胞衍生的趋化因子 (CXCL10 和 CCL2) 增加可能是针对寄生虫的免疫反应极化的血清学标志物

期刊:Cytokine

影响因子:3.7

doi:10.1016/j.cyto.2023.156205

Fabrizio Bruschi, Barbara Pinto, Poupak Fallahi, Silvia Martina Ferrari, Alessandro Antonelli

Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture

帕唑帕尼对原代培养的未分化甲状腺癌的抗肿瘤活性

期刊:International Journal of Molecular Sciences

影响因子:0.7

doi:10.3390/ijms24032398

Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Valeria Mazzi, Armando Patrizio, Simona Piaggi, Enke Baldini, Marco Centanni, Concettina La Motta, Alessandro Antonelli, Poupak Fallahi

Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy

细胞因子 PPAR-gamma 或 PPAR-alpha 激动剂对 Graves 病和眼病原代细胞 CXCL8 与 CXCL10 的差异调节

期刊:Autoimmunity Reviews

影响因子:9.2

doi:10.1016/j.autrev.2019.05.004

Silvia Martina Ferrari, Francesca Ragusa, Sabrina Rosaria Paparo, Francesco Nasini, Marco Nardi, Stefano Sellari Franceschini, Poupak Fallahi, Alessandro Antonelli

Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration

仑伐替尼和凡德他尼对活检或细针穿刺获得的原发性未分化甲状腺癌细胞的抗肿瘤作用

期刊:Frontiers in Endocrinology

影响因子:

doi:10.3389/fendo.2018.00764

Silvia Martina Ferrari, Concettina La Motta, Giusy Elia, Francesca Ragusa, Ilaria Ruffilli, Luca Quattrini, Sabrina Rosaria Paparo, Simona Piaggi, Armando Patrizio, Salvatore Ulisse, Enke Baldini, Gabriele Materazzi, Poupak Fallahi, Alessandro Antonelli

Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer

细胞极性PAR复合物成员在甲状腺癌中的表达及预后价值

期刊:International Journal of Oncology

影响因子:4.5

doi:10.3892/ijo.2017.3907

Chiara Tuccilli, Enke Baldini, Yannick Arlot-Bonnemains, Frank Chesnel, Salvatore Sorrenti, Corrado De Vito, Eleonora D'Armiento, Alessandro Antonelli, Poupak Fallahi, Sara Watutantrige, Francesco Tartaglia, Susi Barollo, Caterina Mian, Stefano Arcieri, Domenico Mascagni, Daniele Pironi, Marco Bonon

Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10

丙型肝炎相关混合性冷球蛋白血症（伴有自身免疫性甲状腺炎）患者血清 CXCL9 水平升高，且与 CXCL10 水平升高相关

期刊:Journal of Interferon and Cytokine Research

影响因子:1.9

doi:10.1089/jir.2012.0091

Alessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari, Michele Colaci, Dilia Giuggioli, Giovanna Saraceno, Salvatore Benvenga, Clodoveo Ferri

CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo

CLM94 是一种具有抗 VEGFR-2 和抗血管生成特性的新型环酰胺，在体外和体内均能有效对抗原发性未分化甲状腺癌

期刊:Journal of Clinical Endocrinology & Metabolism

影响因子:5

doi:10.1210/jc.2011-1987

Alessandro Antonelli, Guido Bocci, Concettina La Motta, Silvia Martina Ferrari, Poupak Fallahi, Ilaria Ruffilli, Andrea Di Domenicantonio, Anna Fioravanti, Stefania Sartini, Michele Minuto, Simona Piaggi, Alessandro Corti, Greta Alì, Teresa Di Desidero, Piero Berti, Gabriella Fontanini, Romano Danes

Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10

循环趋化因子 (CXC 基序) 配体 (CXCL)9 在侵袭性慢性自身免疫性甲状腺炎中增加，与 CXCL10 相关

期刊:Cytokine

影响因子:3.7

doi:10.1016/j.cyto.2011.04.022

Alessandro Antonelli, Silvia Martina Ferrari, Silvia Frascerra, Fabio Galetta, Ferdinando Franzoni, Alda Corrado, Mario Miccoli, Salvatore Benvenga, Aldo Paolicchi, Ele Ferrannini, Poupak Fallahi

免疫

发表日期：2011

文献求助收藏

Evaluation of the Therapeutic Effects of Harmine on Anaplastic Thyroid Cancer Cells

哈尔明对甲状腺未分化癌细胞治疗效果的评价

Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer

人类甲状腺癌中的中性粒细胞胞外陷阱和中性粒细胞相关介质

Increased neutrophil derived chemokines (CXCL10 and CCL2) in human trichinellosis as possible serological markers of the polarization of the immune response against the parasite

人类旋毛虫病中中性粒细胞衍生的趋化因子 (CXCL10 和 CCL2) 增加可能是针对寄生虫的免疫反应极化的血清学标志物

Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture

帕唑帕尼对原代培养的未分化甲状腺癌的抗肿瘤活性

Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy

细胞因子 PPAR-gamma 或 PPAR-alpha 激动剂对 Graves 病和眼病原代细胞 CXCL8 与 CXCL10 的差异调节

Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration

仑伐替尼和凡德他尼对活检或细针穿刺获得的原发性未分化甲状腺癌细胞的抗肿瘤作用

Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer

细胞极性PAR复合物成员在甲状腺癌中的表达及预后价值

Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10

丙型肝炎相关混合性冷球蛋白血症（伴有自身免疫性甲状腺炎）患者血清 CXCL9 水平升高，且与 CXCL10 水平升高相关

CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo

CLM94 是一种具有抗 VEGFR-2 和抗血管生成特性的新型环酰胺，在体外和体内均能有效对抗原发性未分化甲状腺癌

Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10

循环趋化因子 (CXC 基序) 配体 (CXCL)9 在侵袭性慢性自身免疫性甲状腺炎中增加，与 CXCL10 相关